Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01789125 · ClinicalTrials.gov registry record · Phase 1
Smoking Termination / Anxiety Reduction Treatment (ST/ART)
A Phase 1 study, sponsored by University of Houston.
- Completed
- Registry status
- Phase 1
- Development phase
- 74
- Enrollment target
NCT01789125: Completed Phase 1 study, sponsored by University of Houston.
NCT01789125 is a Phase 1 study that has completed, run by University of Houston. The registered enrollment target is 74 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (23% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01789125, a Phase 1 study, has completed, sponsored by University of Houston.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 74 participants
- Enrollment target
Study Summary
The primary aim of this research study is to enhance smoking cessation outcome among smokers with anxiety disorders. The investigators are comparing two group treatment approaches: (1) An educational-supportive psychotherapy and standard smoking cessation treatment, and (2) An integrated smoking cessation and anxiety treatment program (START). Both treatments also utilize nicotine replacement therapy.
Primary Outcome
The investigators will ask participants various questions about their abstinence. The investigators will measure the length of time between when treatment ends and when/ if they start smoking again. The unit of measure will be length of time in days.
Interventions
- DRUG Nicotine Patch
- BEHAVIORAL Smoking Termination and Anxiety Reduction Treatment
- BEHAVIORAL Education-Supportive Psychotherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 74 participants |
| Start Date | 2012-03 |
| Est. Completion | 2016-06 |
| Phase | Phase 1 |
What the finished NCT01789125 record still lists
NCT01789125 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 74 participants, a relatively small participant target, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (23% higher).
The record links to 0 conditions, and to 3 interventions - of which Nicotine Patch is the first listed.
NCT01789125 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01789125 about?
NCT01789125 is a clinical study titled "Smoking Termination / Anxiety Reduction Treatment (ST/ART)". The primary aim of this research study is to enhance smoking cessation outcome among smokers with anxiety disorders. The investigators are comparing two group treatment approaches: (1) An educational-supportive psychotherapy and standard smoking cessation treatment, and (2) An integrated smoking ces...
What is the current status of trial NCT01789125?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 74 participants. The study started on 2012-03. Estimated completion is 2016-06.
What interventions are being tested in trial NCT01789125?
The interventions under investigation include: Nicotine Patch (DRUG), Smoking Termination and Anxiety Reduction Treatment (BEHAVIORAL), Education-Supportive Psychotherapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT01789125?
This trial is sponsored by University of Houston, which has 64 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01789125's enrollment target sits among peer trials
74 725th of 2000 higher than 1,269 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03422731 · 74 participants · Early Phase 1
Multi-modality Imaging and Collection of Biospecimen Samples in Understanding Bone Marrow Changes in Patients With Acute Myeloid Leukemia Undergoing TBI and Chemotherapy
- NCT03804853 · 74 participants · NA
Rehabilitation Following Reverse Total Shoulder Arthroplasty
- NCT04065776 · 74 participants · NA
Evaluation of Hippocampal-Avoidance Using Proton Therapy in Low-Grade Glioma
- NCT04771156 · 74 participants · Phase 4
Ketorolac in Palatoplasty
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia